Founder and Director:
Prof. Susan L. Prescott, University of Western Australia
Susan Prescott is a Professor of Paediatrics in the School of Medicine at University of Western Australia. She is a Paediatrician and an Immunologist, specialising in Allergy at the Perth Children’s Hospital. Susan is a Founding Director of the ORIGINS Project at the Telethon KIDS Institute, a legacy project examining how the environment influences health throughout life. Her interests and expertise are focused around early life risk factors for inflammation as an antecedent (and preventive target) for a broad range of noncommunicable diseases (NCD), with a particular interest in early onset NCDs such as allergy, obesity and mental health. She works at the highest international level of her field, and is a former Director of the World Allergy Organisation. She is also founding President of the multidisciplinary ‘DOHaD’ Society in Australia and New Zealand (Developmental Origins of Health and Disease). She founded and continues to chair the International Inflammation Network (‘in-FLAME’), an interdisciplinary research network with over 300 members from more than 50 partner institutions. She has over 300 scientific publications, and is also author of several books: The Allergy Epidemic – a Mystery of Modern Life (published for an international public audience), The Calling, and Origins - Early Life Solutions to the Modern Health Crisis, and most recently The Secret Life of Your Microbiome: Why Nature and Biodiversity are Essential to Health and Happiness. Susan cares deeply about the social determinants of health, and takes a holistic approach to life. Her inspiration to study medicine came from her grandmother, one of the few women to study medicine in the 1930s, and her love of research and academia was inspired by her grandfather Sir Stanley Prescott, former Vice-Chancellor of The University of Western Australia.
Prof. Dianne E. Campbell, University of Sydney
Professor Dianne Campbell is the Chair of Allergy and Clinical Immunology at Children's Hospital Westmead, Sydney and immediate past Head of the Discipline of Paediatrics and Child Health, Sydney Medical School, University of Sydney. She is the immediate past Chair of the Paediatric Subcommittee for Australian Society for Clinical Allergy and Immunology (ASCIA). She is a member of the WUN in-FLAME network and a CI in the NHMRC centre for research excellent in Paediatric Food Allergy. She completed a PhD at Melbourne University and subsequently held a postdoctoral position at Stanford University, researching in the field of childhood atopic disease (atopic dermatitis and asthma). She has extensive experience in overseeing and developing paediatric graduate and postgraduate curriculum. She has active roles in clinical Allergy and Immunology, Allergy research and Medical Education. Current research areas include: Mechanisms and treatment of childhood atopic dermatitis which focus on T regulatory cell dysfunction in atopic dermatitis; the immuno-biology of FPIES and; the primary prevention and induction of tolerance in food allergy.
The inFLAME Network recognizes our Honorary Fellows for their inspirational vision, community leadership, academic contributions to our field and their support of our Network in various ways.
Professor John Hearn Executive Director, Worldwide Universities Network, Professor of Reproductive Physiology in the School of Medical Sciences at the University of Sydney; Chairman of the Australia Africa Universities Network.
Prof Hearn has been a key champion of inFLAME since its inception, as part of the Worldwide Universities Network (WUN) Public Health initiative. He is a reproductive and developmental physiologist, with 220 research publications and six edited books in human and animal fertility, stem cell biology and biotechnology, his research now is on the science and ethics of stem cell and regenerative medicine, and on reform in international higher education. He was Vice President of the University of Sydney 2004-13; Vice President of the Australian National University (2001-4); and Director, ANU Research School of Biological Sciences (1998-2001). He holds the Scientific Medal of the Zoological Society of London; the Osman-Hill medal of the Primate Society of Great Britain; and the Australian Centenary Medal “for outstanding service to science and to the Australian Government as a scientific adviser”. Born in India, raised in England and Kenya, he graduated BSc, MSc and DSc from University College Dublin; and PhD from the Australian National University (ANU). He served as a researcher, educator and director of national and international programs at the Universities of Edinburgh, London UCL, Wisconsin-Madison, the ANU and Sydney; and as a Senior Scientific Adviser to the World Health Organisation and the World Wildlife Fund. In conjunction with these appointments, he was Director of Science of the Zoological Society of London 1980-87; Deputy Secretary of the Agricultural and Food Research Council of the UK 1987-90; and Director of the Wisconsin National Primate Research Centre 1990-96. He was elected President of the International Primatological Society (1984-8) and of the Society for Reproductive Biology (2001-4). A committed international citizen, he directed research and capacity development programs in Kenya, Brazil, China, Thailand and India.
Prof Tari Haahtela,
Professor Emeritus University of Helsinki.
Prof Haahtela has been a long-time proponent of the Biodiversity Hypothesis - which suggests that contact with natural environments enriches the human microbiome, promotes immune balance and protects from inflammatory diseases. He has been a key advocate for the impact of biodiversity loss and climate change secondary to human activities on human health effects through the loss on environmental and commensal microbiotas. He is the former Head of Skin and Allergy Hospital, Helsinki University Hospital and Chair of the Finnish Asthma Programme 1994-2004. Following the paradigm shift recognizing asthma as an inflammatory condition 1980s, this was the first national program to implement first-line treatment with anti-inflammatory medication. This breakthrough program markedly improved care and and cut health costs for individuals and society. Since the early 2000s his group have been exploring the underlying reasons for the “allergy epidemic” by comparing the Finnish and Russian Karelia to identify the critical environmental and lifestyle determinants. This culminated in the Biodiversity Hypothesis. These novel ideas have been implemented in the Finnish Allergy Programme 2008-2018 which he also chairs. This paradigm is relevant to healthcare and society as a whole, underscoring the importance of natural environments for immune health and noncommunicable disease prevention in general. He has been a Board Member of European Academy of Allergology and Clinical Immunology (EAACI), Global Initiative for Asthma (GINA) and World Allergy Organization (WAO). He was Honorary President of the EAACI Helsinki Meeting 2017. He has published guidebooks on butterflies, which are his hobby. Always ‘thinking outside the box’, Tari linked his hobby and his clinical interest in his publication Allergy is rare where butterflies flourish in a biodiverse environment contributing further to the Biodiversity Hypothesis. He is greatly admired by many in the inFLAME network, as much for his expansive philosophies and forward thinking as for his major contributions to science, health and the community at large.
Prof Stephen Holgate, MRC Professor of Immunopharmacology, University of Southampton.
Prof Holgate is internationally recognised for his research on the mechanisms of asthma and allergy, with a particular interest in the toxicology of air pollutants and the roles of viruses and allergens as drivers of airway inflammation and remodelling. His work has resulted in over 1000 peer reviewed publications and an h index of 155. He has been President of the British Society for Allergy and Clinical Immunology, the British Thoracic Society, the British Association for Lung Research and the Collegium Internationale Allergologicum. He has been Chair of MRC Population and Systems Medicine Board and the MRC Translational Research Group. He is a Trustee of the British Lung Foundation, Cancer Research UK and the Kennedy Trust and chairs the Research Assessment Panel and Research Strategy Committee of the Great Ormond Street Hospital Children’s Charity. In 2003, he cofounded Synairgen, a drug discovery company for respiratory disease and was Founder Chair of the ERS Science Council. He has chaired the UK Government Committee on the Medical Effects of Air Pollutants, the Expert Panel on Air Quality Standards, and the Hazardous Substances Advisory Committee, prior to which he was a member of the Royal Commission on Environmental Pollution. He was a Founder Member of the Academy of Medical Sciences, served on its Council and founded the Clinical and Veterinary Section of the Academia Europaea. In 2011 Stephen was awarded CBE by the Queen in recognition of his contributions to clinical science. His wisdom, experience and philosophies around the values for successful networks have been core values of inFLAME since its inception.
We want to acknowledge our key contributing members who have provided research and strategic leadership for various aspects of the inFLAME network and/or academic and logistic support for our meetings. We welcome contributions from all members. Please contact us if you wish to become a member or make a specific contribution.
Prof Anita Kozyrskyj, University of Alberta
Chair, LactoActive Group
Local Organiser (2018) Alberta, Canada
Senior Fellow, inFLAME
Anita Kozyrskyj is Professor of Pediatrics at the University of Alberta, Canada. Trained as an epidemiologist after being a NICU pharmacist, she is PI of the SyMBIOTA project on environmental shaping of the infant gut microbiome, and development of childhood overweight and atopic disease in the CHILD cohort study. She also leads the LactoActive group of inFLAME and is a ECR mentor.
Prof Cecilie Svanes, University of Bergen
Senior Fellow (Respiratory Medicine and Cohort Studies), inFLAME
Cecilie Svanes, MD PhD, is a professor at the Centre for International Health at the University of Bergen. She has conceived and now leads the ECRHS/ RHINE based multi-centre generation study RHINESSA. Cecilie has been a member of the Steering Committee of the European Community Respiratory Health Study since 1997, and in the ECRHS leads the field of “Early life origins of chronic lung disease”, a field she also leads in the daughter study RHINE. Svanes is also a specialist in pulmonary and in internal medicine, and work as a consultant in occupational respiratory diseases at the Dept Occupational Medicine, Haukeland University Hospital. She is building the only Norwegian facility for occupational specific inhalation challenges at this department.
Dr Jeff Craig, Murdoch Children's Research Institute
Communications and Social Media,
Senior Fellow (Epigenetics), inFLAME. Dr Jeff Craig works in the Environmental and Genetic Epidemiology Research Group at the Murdoch Childrens Research Institute and is an Honorary Associate Professor within the Department of Paediatrics, University of Melbourne. He leads a team of researchers in the Early Life Epigenetics team. He has established a number of longitudinal cohorts including the Peri/postnatal Epigenetic Twins cohort. He aims to apply this work to develop epigenetic biomarkers reflecting past environment and predicting future disease risk.
Prof Christina West, University of Umeå
Senior Fellow (allergy, microbiome, clinical trials) inFLAME
Tina West is a Paediatrician and clinical researcher in the Department of Clinical Sciences, Pediatrics at Umeå University, Umeå, Sweden. She has a specific interest in the role of the Gut Microbiota and the risk of Role in Allergic Disease and leads several clinical trials on this area. She has led the inFLAME Microbiome Working Group since the network began in 2012, including a series of collaborative projects and position statements.
Prof. Maria Jenmalm, Linköping University
Senior Fellow (Microbiome and Experimental Allergology), inFLAME
Maria Jenmalm is Professor of Experimental Allergology in the Faculty of Medicine and Health Sciences at Linköping University. Her main interests are in childhood immune maturation and allergy development, including epigenetic regulation by maternal immunity and microbial exposure during pregnancy. She has been a major contributor to several collaborative inFLAME projects, including position papers and experimental studies.
Prof. Catherine Thornton, Swansea University
Senior Fellow (Immunobiology and Metabolism), inFLAME
Cathy Thornton is Professor of Human Immunology and Deputy Head of Swansea University Medical School. She is Designated Individual for the Medical School’s HTA Human Tissue Research Licence. Cathy’s core research interest is the antenatal determinants of immune health in childhood. This encompasses work on the immune response in pregnancy, especially of the placenta, and post-natal development of immune function in early life with a special interest in the impact of maternal obesity.
Prof Carel Thijs, Maastricht University
Local Organiser (2016), Maastricht Netherlands.
Senior Fellow (Cohort Studies), inFLAME
Carel Thijs was trained as a medical doctor, epidemiologist and physician in Public Health. His main research interest is lifecourse epidemiology in the domains of allergy, infections and overweight. He inititiated the KOALA-study and coordinates its many projects and supervises the PhD-fellows and collaborating researchers
Prof. Michael Levin, University of Cape Town Local Organiser (2014), Cape Town South Africa. Senior Research Fellow (Cohort Studies), inFLAME
Mike Levin is head of the Division of Asthma and Allergy in the Department of Paediatrics and Child Health, University of Cape Town.
He also leads the South African Food Sensitisation and Food Allergy (SAFFA) study, which assesses an unselected cohort of children (age 12-36 months) in urban Cape Town and a rural cohort of 400 black African (Xhosa) children in the Eastern Cape, to determine the prevalence of sensitisation and true IgE-mediated food allergy.
Prof. Felice Jacka, Deakin University, University of Melbourne.
Chair, Mental Health, Senior Fellow (Mental Health and Nutrition) inFLAME.
Felice Jacka is the Director of the Food and Mood Centre within the Deakin University School of Medicine in Geelong. She is also an honorary Principal Research Fellow with the Department of Psychiatry at the University of Melbourne, The Centre for Adolescent Health at the Murdoch Childrens Research Institute, and at the Black Dog in NSW. She has has pioneered a highly innovative program of research that examines how individuals’ diets interact with the risk for mental health problems. This research is being carried out with the ultimate goal of developing an evidence-based public health message for the primary prevention of the common mental disorders.
Dr Donna Geddes, University of Western Australia
Senior Fellow (Breast milk Studies), inFLAME
Donna is the director of the Human Lactation Research Group. Donna originates from a medical imaging background with an emphasis in ultrasound imaging. She has integrated this modality into many of the group’s studies providing a ‘window’ to different physiological processes during lactation. She has a broad range of research interests in the physiology of lactation extending from basic to applied research. In particular she utilizes her ultrasound imaging skills to assess the lactating breast (anatomy, milk ejection and blood flow) as well as the infant (suck-swallow-breathe, gastric emptying and body composition).
Prof Christine Cole-Johnson, Henry Ford Health System
Senior Fellow (Epidemiology and Cohort Studies), inFLAME
Chris Cole-Johnson is Professor of Obstetrics and Gynecology, Wayne State University and Chair, Public Health Sciences, Henry Ford Health System. She is leader of the Trans-American Consortium for the Health Care System Research Network - part of the NIH Precision Medicine Initiative Cohort Program, which hopes to collect and analyze the personal health and lifestyle information, and biological samples, of as many as a million people over several years. She is an epidemiologist with a strong research focus on health during infancy and the epidemiology and etiology of allergic disorders, with the goal of the primary prevention of allergy and asthma. Her research team is focused on prenatal and early infancy characteristics related to immune development, inflammation and pediatric health.
Prof Annika Scheynius, Karolinska Institutet, Stockholm
Senior Fellow (Immunomodulation and Allergic Disease), inFLAME.
Annika Scheynius is a Professor senior in Clinical Allergy Research at the Department of Clinical Science and Education,
Karolinska Institutet, and Sachs' Children and Youth Hospital, Södersjukhuset. Her interests include allergic diseases and elucidating mechanisms that determine whether or not an exposed individual will become sensitised to allergens with a focus on host-microbe and gene-environment interactions. Her research focusses on how immune regulatory mechanisms can be used for prevention and treatment.
Dr Debbie Palmer, University of Western Australia
Senior Fellow (Allergy and Nutrition), inFLAME
Dr Debbie Palmer (BSc, BND, PhD) is head of the Childhood Allergy and Immunology Research Team at the University of Western Australia. She is one of a few dietitians worldwide undertaking research in the area of nutritional strategies for allergy prevention. After ten years of clinical paediatric dietetic experience and specialising in the area of food allergy, Debbie commenced her research career. Her current research activities include conducting randomised controlled trials focusing on nutritional interventions for the prevention of allergic disease.
Prof Rose Kamenwa, Aga Khan University, Kenya.
Senior Fellow (Gastroenterology and Nutrition), inFLAME
Rose Kamenwa is Assistant Professor, Full Time Faculty and Paediatric Gastroenterologist, in the Department of Paediatrics and Child Health at Aga Khan. Her research interests are in Food Allergy and Gastrointestinal Diseases. She has a particular interest in describing patterns of food allergens in children and Vitamin D status in exclusively breastfeeding infants in Kenya.
Prof David Fleischer, University of Colorado
Senior Fellow (Allergy and Immune Tolerance), inFLAME
David Fleischer is associate Professor in pediatrics and allergy at the Children's Hospital Colorado. His primary clinical interest is in food allergy. His research focuses on food allergy, in particular peanut and tree nut allergies. He is interested in why certain patients with food allergies outgrow them more readily and sooner than others. He has an interest in novel treatments for food allergy, including oral and sublingual immunotherapies.
Dr Jon Genuneit, Ulm University, Germany
Senior Fellow (Epidemiology), inFLAME
Jon Genuneit is Deputy Director of the Institute of Epidemiology and Medical Biometry. His research is focused on chronic disease in childhood, among others on phenotyping and the environmental and genetic determinants of asthma and allergies. He has further focus on psychosocial strains and sleep in the family.
Prof Harald Renz, Marburg University
Local Organiser (2015), Marburg Germany.
Senior Fellow (Immunobiology), inFLAME
Harald Renz, is director and chairman of the Institute of Laboratory Medicine and Pathobiochemistry of the Philipps-University Marburg, Germany. He is past-president of the German Society of Allergology and Clinical Immunology, and coordinates the inter-regional Research Consortium of Allergies and Asthma, funded by the German Research Council. His research interest is the pathogenesis of allergies and asthma. He has made major contributions in the field of the origin of asthma, with regard to the pre- and postnatal environment, as well as to the development of animal model systems representing different phenotypes of allergies and asthma.
Dr Daniel Munblit, Imperial College London
Chair, Early Career Research (ECR) Group, Early Career Fellow (breast milk research), inFLAME
Daniel is an honorary Research Associate at Department of Paediatrics, St Mary's Campus at Imperial College London (ICL) where he completed his PhD. Dr Munblit graduated from a Moscow State Medical University in 2003 and then been trained at the Moscow Institute of Paediatrics and Child Surgery. He coordinated EU Horizon 2020 application (BIRTH project) from ICL in 2014. Dr. Munblit is one of the coordinators of the work of in-FLAME Breast Milk Research working group LactoActive and the inFLAME ECR group.
A/Prof Susanne Brix, Technical University of Denmark
inFLAME Database Coordinator
Senior Fellow, inFLAME
Susanne Brix is an associate professor at the Department of Systems Biology at Technical University of Denmark. Her interests are in the Systems Biology of Immune Regulation, particularly the influence of microbial exposures on immune development and disease risk. She coordinates the compilation of cohort metadata within the inFLAME network.
Prof. Karsten Christiansen, University of Copenhagen
Chair, Systems Biology
Senior Fellow (Microbiome and Metabolomics), inFLAME
Karsten Kristiansen, is Professor of Molecular Biology and Head, Genomics and Molecular Biomedicine, at the University of Copenhagen, He is also a Senior advisor to BGI-Shenzhen, China. He has extensive experience with studies of Gut Microbiota in Health and Disease, and is interested in integrating research frameworks for improving human and environmental health.
Prof John Penders, Maastricht University
Local Organiser (2016), Maastricht Netherlands.
Senior Fellow (Microbiome and metabolomics), inFLAME
John Penders is as an assistant professor at the Department of Medical Microbiology at Maastricht University Medical Center. His research line focuses on the role of the intestinal microbiota in health and disease and as a reservoir of antimicrobial resistance. He is specifically interested in the developing microbiota in early life and aims to identify pertubations in the microbiota that contribute to the onset of diseases such as allergies and metabolic disorders
Dr Chrysanthi Skevaki, Marburg University
Co-Chair, Early Career Research Group,
Early Career Fellow, inFLAME
Originally from Greece, Chrysanthi Skevaki
is now a Physician Specialist at the University of Marburg. Her research interests include the role of upper viral respiratory tract infections in early life and the subsequent predisposition to asthma and atopy later in life. She supports Dr Daniel Munblit in the ECR activities of the inFLAME network.
Kyra Jones, Early Career Researcher, Henry Ford Health System, Detroit.
Assistant to Local Organisers (2017), Early Career Fellow, inFLAME.
Prof Naoki Shimojo, Chiba University
Senior Fellow (Immune regulation), inFLAME
Naoki Shimojo is Chairman of Department of Pediatrics, Graduate School of Medicine, Chiba University - one of the leading medical centers for child health and development in Japan. The service provides high-quality health care for all kinds of severe, emergent or chronic diseases in childhood. They collaborate with families, other healthcare professionals and satellite hospitals to cure and care for sick children. His group is dedicated to promoting basic and/or clinical research as our mission as an academic medical centre - with a specific interest in allergic diseases and immune disorders.
Prof Ralph Nanan, University of Sydney
Senior Fellow (Immuneregulation), inFLAME
Professor Nanan’s main areas of interest are the developmental origins of health and disease with a specific focus on paediatric clinical immunology, allergy and perinatology. His group was the first to provide evidence that preeclampsia, the most common and serious pregnancy related disorder, is likely to be the result of an imbalance between T-regulatory and TH17 cells, which consequently leads to rejection of the fetus by the maternal immune system.
He is currently investigating factors responsible for fetal immune programming including maternal diet, gestational diabetes, obesity and environmental determinants.
Prof. Johan Garssen, Utrecht University Senior Fellow (Immunomodulation and Early Life Nutrition), inFLAME
Johan Garssen is Professor Immunopharmacology at Utrecht University and Head Division of Pharmacology at Utrecht Institute for Pharmaceutical Sciences.
He studied medicine and biology at the Free University, Amsterdam, and specialised in immunology, pharmacology and biochemistry. He was appointed director of the immunology platform of Nutricia Research in 2008. His research interests include both preclinical as well as clinical research, in the field of immunomodulation induced by nutritional ingredients, drugs and environmental agents.
Dr Carina Venter, University of Southampton and Cincinnati Center for Eosinophilic Disorders
Senior Fellow (Early Life Nutrition), inFLAME
Carina Venter PhD, RD, is an Allergy Specialist dietitian, working with children and adults diagnosed with food allergies. Carina graduated as a dietitian in South Africa in 1993. In 1997 she moved to the United Kingdom and worked at the Good Hope Hospital in Sutton Coldfield before moving to the Isle of Wight. She has a particular interest in the role of nutrition in the prevention, diagnosis and management of allergic diseases. In recognition of her major contributions to the field she was awarded a Fellowship from the British Dietetic Association (2016) and received and honorable mention of the Pharf award, European Academy of Allergy and Clinical Immunology, June 2016
Prof Merete Eggesbø of Norwegian Institute of Public Health, Oslo
Senior Fellow (Environmental health and human milk), inFLAME
Merete Eggesbo is a senior researcher, is an epidemiologist with main interests in persistent environmental toxicants and child health. She is the founder and principal investigator of the Norwegian Human Milk Study (HUMIS), which aims at assessing the effect of exposure to persistent environmental toxicants on child health. At NFI, she works closely with The National Institute of Environmental Sciences (NIEHS, North Carolina, US) involving research on the environmental samples in MoBA (Norwegian mother child cohort of 100 000 children). Furthermore, she is responsible for Norway’s contribution to the WHO monitoring program of environmental pollutants in milk.
Prof Ruby Pawankar, Nippon Medical School in Tokyo, Japan
Senior Fellow (Allergy and Cell Biology), inFLAME.
Ruby Pawankar has been President of the World Allergy Organisation (WAO), 2012 and 2013. Currently she is Professor of Allergy, Department of Pediatrics at Nippon Medical School in Tokyo, Japan. She is a Council member of Collegium Internationale Allergolicum and President- Elect APAAAC. Her research has focused on the cellular and molecular mechanisms of allergy, impact of environmental pollutants, and novel therapies for allergies. Among her key contributions is the role of gamma delta T cells in allergy and that of mast cells with increased Fce receptor expression as a major source of obligatory pro-allergic Th2 cytokines driving local allergen-specific IgE synthesis. She has worked on the role of environmental factors including particulate matter and mite allergens on respiratory allergies and the role of epithelial cells in regulating immune inflammation in allergic airway disease. Her current interest is on the microbiome and biomarkers in allergy.
Prof Bianca Schaub, LMU Munich, University Children´s Hospital, Munich
Senior Fellow (Immunobiology), inFLAME
Bianca Schaub is head of the Allergy-Immunology research group and Deputy Head of the Asthma and Allergy Department and Attending at the Pulmonary Department of Munich University Children´s Hospital, Munich, Germany. The main research interest of her group is to identify immunological mechanisms in the development of allergic diseases in childhood. Ongoing projects in several national and international birth cohort studies include the influences of regulatory immune responses of the infant immune system in the development of allergic diseases in childhood. Dr. Schaub has a strong interest in the effect of early maternal and environmental factors on the development of the fetal and infant immune system and subsequently the allergic phenotype. Prof. Dr. Schaub has received several prestigious Research Awards (Klosterfrau Research Award 2009, Pediatric Respiratory Research Award from ERS 2010, Johannes Wenner Award of GPP 2013, Henning Lowenstein Research Award 2013 of WAO, the Research Award 2013 from GPA, and the DGAKI Research Award 2016, German Assoc. of Allergy and Immunology).
Prof Valérie Verhasselt, Université de Nice Sophia Antipolis and University of Western Australia
Senior Fellow (Immune Tolerance and Breast Milk Research), inFLAME.
With a background of Medical Doctor, Specialist in Internal Medicine and a PhD in Immunology (Université Libre de Bruxelles), Valérie Verhasselt has developed unique mouse models to address hypothesis and understand mechanisms of action of maternal impact on immune development through breast milk. She further translates mouse models significant results into the human using mother-child birth cohorts. Major research accomplishments in the last 10 years are the understanding of how breast milk can impact on tolerance induction with long term consequences on allergy susceptibility. The understanding of this process will impact on development of strategies for allergy prevention and of novel oral vaccinations protocols. Valérie Verhasselt was recently offered a Chair in Human Lactology at the University of Western Australia (Perth) where she will settle with her team in 2017
Dr Ganesa R Wegienka, Henry Ford Health System
Chair, Planetary Health
Local Organiser (2017), New York USA
Senior Fellow, inFLAME
Ganesa Wegienka’s research interests include causes of pediatric allergic diseases such as allergy and asthma, as well as the racial disparities observed in their occurrence. To this end, she has received funding from the NIH to investigate the role of vitamin D in racial disparities in pediatric allergic diseases in the WHEALS cohort. Dr. Wegienka also serves as a research advisor to the fellows in training in the Division of Allergy and Immunology.
Dr Alan C. Logan, New York
Chair, Natural Environments
Local Organiser (2017), New York USA. Senior Fellow, inFLAME
Alan Logan is an independent researcher, biophilosopher, and Fellow of the Royal Society of Public Health. For almost 20 years Alan has authored academic articles with university-based physicians and scientists. For over 10 years Alan was an invited faculty member in the mind-body medicine courses at Harvard's School of Continuing Medical Education and contributed to Harvard School of Public Health's Natural Environments Initiative. He set forth the first contemporary
framework for the ways in which the manipulation of microbiota could influence fatigue (2003) and depression (2005). He is highly respected for his endeavours in the scientific exploration of biopsychosocial and ecological influences in health.
Dr Glenn Albrecht, Honorary Fellow in the School of Geosciences, The University of Sydney. Senior Fellow (Environmental Philosophy), inFLAME
Glenn Albrecht retired as professor of sustainability at Murdoch University in Perth in 2014. He is an environmental philosopher with both theoretical and applied interests in the relationship between ecosystem and human health, broadly defined. He has pioneered the research domain of 'psychoterratic' or earth related mental health and emotional conditions with his concept of 'solastalgia' or the lived experience of negative environmental change. His current major transdisciplinary research interest, the positive and negative psychological, emotional and cultural relationships people have to place and its transformation is one that sees him having a national and international research profile in an emergent field of academic inquiry where he has been recognised as a global pioneer. New concepts such as his idea of ‘The Symbiocene’ are also attracting international interest.
Professor Philip Calder, University of Southampton
Senior Fellow (Nutritional Immunology), inFLAME
Philip Calder is Professor of Nutritional Immunology within Medicine at the University of Southampton He has broad research interests in nutritional modulation of immunity, inflammation and cardiometabolic disease risk. Much of his work has been devoted to exploring the metabolism and functionality of fatty acids with an emphasis on the roles of omega-3 fatty acids. He is Chair of the Scientific Committee of the European Society for Clinical Nutrition and Metabolism (ESPEN) and President of the Nutrition Society. He is a member of the several other Editorial Boards of journals in the nutrition, clinical science and lipidology fields. With over 500 scientific publications, he is listed by Thomson Reuters as a Highly Cited Researcher. “ My work aims to understand how nutrition affects the functioning of the human body. Better understanding is key to developing strategies to improve human health and well-being, to lower disease risk and to treat nutrition-related illnesses”
Dr. Takaro Professor and Associate Dean Research, Faculty of Health Sciences at Simon Fraser University. Senior Fellow (Climate Change, Environmental and Human Health), inFLAME
Dr. Takaro is a physician-scientist trained in occupational and environmental medicine, public health and toxicology, at Yale, the University of North Carolina and University of Washington. Dr. Takaro’s research is primarily about the links between human exposures and disease, and determining effective public health based preventive solutions to such risks. He helps direct the exposure assessment component of CHILD birth cohort. His current research on human health and climate change focuses on water quality, extreme weather events and gastro-intestinal illness and the role of aero-allergens in the development of asthma in children..
Dr Hani Harb, Harvard Medical School
Local Organiser (2015), Early Career Research Fellow (Epigenetics), inFLAME
Hani completed his PhD with Dr Harald Renz's group in Marburg Germany and has taken a leading role in a series of collaborative epigenetics studies with other inFLAME researchers in both humans and animal models. He also assisted in organising the very popular inFLAME annual 2015 conference in Marburg. He is now at Harvard Medical School in the Division of Immunology at the The Boston Children's Hospital.
Jenni Lehtimäki, Early Career Researcher, University of Helsinki. Early Career Fellow, inFLAME (Master of science in ecology and evolutionary biology)
Jenni applies her ecological knowledge to human microbiota research. She will defend her PhD in autumn 2017, titled: “The biodiversity hypothesis of allergy: The interrelations between microbiota, allergic diseases and exposure to microbes in residential environments”. Jenni is passionate about the determinants of the microbial species composition in humans. Her work addresses the factors that modify microbiota and their relative importance in shaping human health. Besides humans, Jenni has used pet dogs as a model animal for understanding the associations between living environment, microbiota and allergic diseases.
Andrew Bossick, Early Career Researcher, Henry Ford Health System, Detroit.
Assistant to Local Organisers (2017), Early Career Fellow, inFLAME.
Andrew S. Bossick, MPH is a master's level epidemiologist at Henry Ford Health System, in Detroit, Michigan. He will soon be pursuing a PhD in Public Health at the University of Washington, United States, as a T32 Agency for Healthcare Research and Quality (AHRQ) National Research Service Award (NRSA) fellow. His research interests include racial disparities, maternal and child health, and environmental impact on perinatal and postnatal health and disease.
Prof. John Holloway, University of Southampton
Senior Fellow (Genetics), inFLAME
John Holloway is Professor of Allergy and Respiratory Genetics within Medicine at the University of Southampton. He now heads the Respiratory Genetics Group, based in the Human Development and Health and Clinical and Experimental Sciences Academic Units. The Respiratory Genetics Group undertakes a number of research projects into the genetic basis of allergy, asthma and other respiratory diseases. Research highlights include the identification of the gene ADAM33 as an asthma susceptibility gene, as published in Nature.
Dr Peter Hsu, University of Sydney
Early Career Fellow (Immuneregulation), inFLAME. Photographer in residence.
Peter Hsu is a consultant allergist and immunologist at the Westmead Children's Hospital and a Senior Lecturer in Paediatrics and Child Health at the University of Sydney. His main research interests are in the regulatory immune mechanisms in food allergies.
Prof Peter Vuillermin, Deakin University
Senior Fellow (Early Life Origins of Immune Disorders, Birth Cohorts), inFLAME
Peter Vuillermin is a general paediatrician with an interest in the early life origins of immune related disorders in the modern environment. Peter is co-lead investigator on the Barwon Infant Study, which is a population-derived Australian birth cohort study (n=1074) incorporating longitudinal assembly of uniquely detailed array of biological samples in combination with environmental and clinical data. He has a particular interest in the relationship between the modern environment and diet, the microbiome and its metabolites, and the early life origins of immune dysregulation, allergic disease and asthma.
Prof Alan Landay, Rush University
Senior Fellow (Infection and Immunity), inFLAME
Alan Landay is the chairperson of the Department of Immunity & Emerging Pathogens and principal investigator of the Rush Immunology Specialty Laboratory (ISL), with 35 years experience in studies of HIV immunopathogenesis. He has worked with the AIDS Clinical Trials Group since its beginning and has directed the ISL since it began.
His studies on immunophenotyping and innate immunity in HIV disease have made significant contributions to this field. These early studies were carried out in a newly recognized population of hemophiliacs that were shown to develop AIDS. His work was extended to define monocyte subsets and the critical role of monocytes and innate immune cell activation in HIV pathogenesis. These papers have contributed to a shift in thinking about HIV as an adaptive immune disease to one focused on innate cell driven inflammation linked to the development of immunosenescence.
Dr Jakob Stokholm, University of Copenhagen
Early Career Fellow (Microbial Ecology and Childhood Development), inFLAME
Jakob Stokholm received his medical degree from the University of Copenhagen in 2006, and has later been employed for 1½ year at the paediatric department at Næstved Sygehus. Jakob finished his PhD-thesis: “Antibiotic Administration and Factors Influencing the Vaginal Microbiota during Pregnancy” about antibiotics and vaginal ecology during pregnancy in a Danish cohort of 743 women (COPSAC-2010) in 2012.
Now Jakob Stokholm is continuing his research as a post.doc. at COPSAC with the focus on the earliest bacterial ecology and environmental influence of children and the development of disease in childhood.
Dr. Kirsi Järvinen-Seppo Rochester School of Medicine and Dentistry, Rochester, NY Senior Fellow (Breast Milk Research), inFLAME
Kirsi Järvinen-Seppo is the Chief and Founder’s Distinguished Chair of Pediatric Allergy and Immunology and the Director of the Center for Food Allergy at the Golisano Children’s Hospital. She completed her M.D. and Ph.D. at the University of Helsinki, and her research fellowship in the Jaffe Institute for Food Allergy at the Mount Sinai School of Medicine, New York. Her research program is focused on identifying mechanisms that support the development of oral tolerance. Utilizing animal models and human cohorts, she is studying the role of breast milk bioactive components and early environmental farm exposures in the development of infant mucosal and systemic immune system, microbiome and atopic diseases. These studies will allow for strategies in primary prevention of allergic diseases aimed at infants and/or their mothers.
Dr Daniel P. Potaczek, Marburg University
Early Career Fellow (Epigenetics), inFLAME
Daniel P. Potaczek is a junior group leader (funded by the German Center for Lung Research – DZL) at the Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, the University of Marburg. His current research focuses on the role of epigenetic mechanisms in chronic inflammatory disorders, especially allergies and asthma.